NanoVibronix, Inc. (NAOV)

NASDAQ: NAOV · Real-Time Price · USD
0.9001
-0.0801 (-8.17%)
At close: Jun 17, 2025, 4:00 PM
0.9200
+0.0199 (2.21%)
After-hours: Jun 17, 2025, 6:02 PM EDT
-8.17%
Market Cap 2.33M
Revenue (ttm) 2.66M
Net Income (ttm) -5.61M
Shares Out 2.58M
EPS (ttm) -15.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 724,135
Open 0.9500
Previous Close 0.9802
Day's Range 0.8400 - 0.9500
52-Week Range 0.6669 - 16.2500
Beta 1.76
Analysts n/a
Price Target n/a
Earnings Date May 20, 2025

About NAOV

NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is design... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 31
Stock Exchange NASDAQ
Ticker Symbol NAOV
Full Company Profile

Financial Performance

In 2024, NanoVibronix's revenue was $2.56 million, an increase of 12.05% compared to the previous year's $2.28 million. Losses were -$3.71 million, -0.16% less than in 2023.

Financial Statements

News

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through its ENvue...

6 days ago - Business Wire

NanoVibronix Announces CEO Transition

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the retirement of ...

13 days ago - Business Wire

NanoVibronix Responds to False Post

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) confirmed that a series of posts made earlier today with respect to a $26 million registered direct offering of common ...

20 days ago - Business Wire

Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through its ENvue...

20 days ago - Business Wire

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the closing of its...

4 weeks ago - Business Wire

NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the pricing of an ...

4 weeks ago - Business Wire

NanoVibronix Announces Results from UroShield™ Case Series

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in therapeutic devices, today announced findings from a recent retrospective...

5 weeks ago - Business Wire

NanoVibronix Regains Nasdaq Compliance

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company” or “NanoVibronix”), a medical technology company specializing in non-invasive therapeutic devices, today announced tha...

2 months ago - Business Wire

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company” or “NanoVibronix”), a medical technology company specializing in non-invasive therapeutic devices, today announced the...

2 months ago - Business Wire

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced that an independent h...

3 months ago - Business Wire

NanoVibronix Announces Reverse Stock Split

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced that ...

3 months ago - Business Wire

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced the completion of the...

4 months ago - Business Wire

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Port...

5 months ago - Business Wire

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Port...

5 months ago - Business Wire

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Por...

6 months ago - Business Wire

NanoVibronix Provides Business Update

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portab...

7 months ago - Business Wire

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (“SAW”) P...

8 months ago - Business Wire

NanoVibronix Signs Letter of Intent with Potential New Distributor

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Por...

9 months ago - Business Wire

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

10 months ago - Business Wire

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

1 year ago - Business Wire

NanoVibronix Issues Letter to Stockholders

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Th...

1 year ago - Business Wire

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acousti...

1 year ago - Business Wire

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acous...

1 year ago - Business Wire

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

1x1 Meetings on Thursday, May 2, 2024 ELMSFORD, NY / ACCESSWIRE / April 24, 2024 / NanoVibronix, Inc. (Nasdaq:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShi...

1 year ago - Accesswire

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoust...

1 year ago - Business Wire